Idéal Investisseur
Français English
CAC 40 :
8 157,82 pts
-0.84%


Last updated : 24/04/2026 - 17h35 (last close)
Last close data
🏠 Home   ➤    Stock news

Eurofins Scientific Shares Fall 2.17% at Tuesday's Close


Eurofins Scientific Shares Fall 2.17% at Tuesday's Close

Eurofins Scientific shares closed the Tuesday session on January 20 at 70.36 euros, down 2.17% from the previous day's close of 71.92 euros. This correction follows an outstanding twelve-month performance, with the share price having increased by 49.48%. However, the value of the analysis laboratory specialist remains well-oriented over three months with a gain of 12.54%. Technically, the RSI shows a level of 85, indicating an overbought zone that could justify this pause. Nevertheless, the price continues to move above its 50-day (61.71 euros) and 200-day (60.86 euros) moving averages, confirming the strength of the underlying bullish trend. The proximity of the resistance threshold at 73.12 euros poses a short-term obstacle for the continuation of the movement.

Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
Before 9 AM every morning Euronext data AI-powered analysis

The group continued its share buyback program with the acquisition of 30,000 shares between January 12 and 16 at an average price of 71.91 euros, after having bought back 70,000 shares at the beginning of January for 4.7 million euros. This strategy reflects the management's confidence in the stock's prospects. On the analyst side, Kepler Cheuvreux raised its price target to 81 euros from 72 euros previously on January 13, while Morgan Stanley raised it to 64 euros at the beginning of January. These recommendations suggest a potential upside of 15.16% for the highest target compared to the current price. Bernstein, meanwhile, maintains an outperformance recommendation with a target of 72.30 euros.



Sector Santé · Pharmacie Services médicaux


Assurance vie

Context

Period
  • Period: 2025
Key reported figures
  • Revenue: 7 296 M€
  • Revenue growth: 5,0%
  • EBITDA: 1 561 M€
  • EBITDA margin: 21,4%
  • Net income: 473 M€
  • Free cash flow: 876 M€
  • Net debt: 3 641 M€
  • Dividend per share: 0,72 €
Guidance from the release
  • Nous sommes satisfaits d’avoir atteint nos objectifs 2025 et de démontrer la solidité du portfolio Eurofins.
  • La performance 2025 est soutenue par la croissance organique et l’expansion des marges, avec un flux de trésorerie libre robuste et un endettement maîtrisé.

The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.

Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.

Advertisement
Every morning
Technical market signals,
before the opening bell.
CAC 40 · SBF 120 · Signals · Analysts
🤖
Today's edition — pre-market
CAC 40
7 702
-0,87%
SBF 120
5 827
-0,87%
📈 Bullish signals
+5,2%
+1,8%
+0,9%
📉 Bearish signals
-14%
-5,7%
🔄 Analyst opinions
▲ 35 €
▼ 80 €
Sign up to see everything →
Before 9 AM every morning
Euronext data
AI-powered analysis





BOURSE · Chaque matin
La synthèse bourse,
avant l'ouverture.
Notre moteur analyse chaque nuit le CAC 40 et le SBF 120. Ce qui mérite attention remonte directement dans votre boîte mail. Gratuit.
Avant 9h00 1000+ inscrits 100% gratuit